The CNS wishes to publish this opinion today, at a time when a committee of experts recommended the FDA to approve a supplemental New Drug Application for an antiretroviral treatment to be used for PrEP.
You will find on this website :
the complete Opinion
the Summary of the Opinion in pdf format
the Press release
